Cassava Sciences Inc (SAVA)
20.56
+0.04
(+0.17%)
USD |
NASDAQ |
Apr 24, 13:42
Cassava Sciences Total Assets (Quarterly): 151.66M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 151.66M |
| September 30, 2023 | 172.53M |
| June 30, 2023 | 197.25M |
| March 31, 2023 | 218.11M |
| December 31, 2022 | 234.83M |
| September 30, 2022 | 207.29M |
| June 30, 2022 | 227.38M |
| March 31, 2022 | 244.19M |
| December 31, 2021 | 266.78M |
| September 30, 2021 | 274.25M |
| June 30, 2021 | 281.30M |
| March 31, 2021 | 284.05M |
| December 31, 2020 | 94.30M |
| September 30, 2020 | 25.40M |
| June 30, 2020 | 25.50M |
| March 31, 2020 | 25.98M |
| December 31, 2019 | 23.49M |
| September 30, 2019 | 18.38M |
| June 30, 2019 | 18.80M |
| March 31, 2019 | 19.52M |
| December 31, 2018 | 20.14M |
| September 30, 2018 | 20.84M |
| June 30, 2018 | 9.833M |
| March 31, 2018 | 11.06M |
| December 31, 2017 | 10.83M |
| Date | Value |
|---|---|
| September 30, 2017 | 12.38M |
| June 30, 2017 | 14.27M |
| March 31, 2017 | 17.60M |
| December 31, 2016 | 19.30M |
| September 30, 2016 | 22.48M |
| June 30, 2016 | 24.94M |
| March 31, 2016 | 28.63M |
| December 31, 2015 | 31.92M |
| September 30, 2015 | 35.65M |
| June 30, 2015 | 37.76M |
| March 31, 2015 | 39.64M |
| December 31, 2014 | 40.91M |
| September 30, 2014 | 43.59M |
| June 30, 2014 | 45.39M |
| March 31, 2014 | 47.32M |
| December 31, 2013 | 50.10M |
| September 30, 2013 | 51.76M |
| June 30, 2013 | 53.20M |
| March 31, 2013 | 54.87M |
| December 31, 2012 | 56.86M |
| September 30, 2012 | 93.26M |
| June 30, 2012 | 94.44M |
| March 31, 2012 | 96.81M |
| December 31, 2011 | 98.96M |
| September 30, 2011 | 100.59M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
18.38M
Minimum
Sep 2019
284.05M
Maximum
Mar 2021
157.45M
Average
197.25M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Amylyx Pharmaceuticals Inc | 517.45M |
| MannKind Corp | 475.20M |
| Clearside Biomedical Inc | 34.02M |
| Lantern Pharma Inc | 43.65M |
| NovaBay Pharmaceuticals Inc | 9.034M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.20M |
| Shareholders Equity (Quarterly) | 137.47M |